Loading...

Showing 36 results.

Thumbnail for Total Hip Arthroplasty Patients Requiring Acute Pain Service Consultations: A Registry Study

2316875

Total Hip Arthroplasty Patients Requiring Acute Pain Service Consultations: A Registry Study

Maya Tailor, Junying Wang, William Chan, Mary Kelly, Jennifer Terry, Dae Kim, Spencer Liu, Stavros Memtsoudis, Jiabin Liu, Jashvant Poeran, Seth Waldman, Daniel Maalouf, Yuhua Bao, Faye Rim,...

Hospital for Special Surgery, Pain Prevention Research Center, Department of Anesthesiology, Critical Care, and Pain Management, Hospital for Special Surgery, Center for Analytics, Modeling, and Performance (CA...

Poster Presenter: Maya Tailor

Thumbnail for Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after herniorrhaphy

2317724

Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after herniorrhaphy

Fernando Cabrera, Todd M. Bertoch, Jessica C. McCoun, Harold S. Minkowitz, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith

Viatris, Viatris, Morgantown, WV, USA, CenExel JBR, Salt Lake City, UT, USA, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg, PA, USA, Evolution Research Group, Bellaire, Texas, USA, Viatris, Bad Homburg,...

Poster Presenter: Fernando Cabrera

Thumbnail for Opioid sparing effect of MR-107A-02 for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy

2317792

Opioid sparing effect of MR-107A-02 for the treatment of acute moderate-to-severe pain following bunionectomy and herniorrhaphy

Fernando Cabrera, Todd M. Bertoch, Ira Gottlieb, Harold S. Minkowitz, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith

Viatris, Viatris, Morgantown, WV, USA, CenExel JBR, Salt Lake City, UT, USA, Chesapeake Research Group, Pasadena, Maryland, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg, PA, USA, Evolution Research Gro...

Poster Presenter: Fernando Cabrera

Thumbnail for Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after bunionectomy

2317850

Efficacy and safety of MR-107A-02 (novel meloxicam formulation) for treatment of acute moderate-to-severe pain after bunionectomy

Jennifer D Shedden, Jessica C. Mc Coun, Ira Gottlieb, Susanne Vogt, Scott Haughie, Kathleen Ocasio, Jeffrey P. Smith, Todd M. Bertoch

Viatris, Viatris, Morgantown, WV, USA, CenExel AMCR, Atlanta, Georgia, Chesapeake Research Group, Pasadena, Maryland, Viatris,Bad Homburg, Hessen, Germany, Viatris/Mylan Pharma UK Ltd, Viatris Inc., Canonsburg,...

Poster Presenter: Jennifer Shedden

asraspring2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.